Literature DB >> 10952713

Promising stratagems for reducing the burden of neonatal sepsis.

N Modi1, R Carr.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952713      PMCID: PMC1721128          DOI: 10.1136/fn.83.2.f150

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


× No keyword cloud information.
  34 in total

1.  Distinguishing between "no evidence of effect" and "evidence of no effect" in randomised controlled trials and other comparisons.

Authors:  W O Tarnow-Mordi; M J Healy
Journal:  Arch Dis Child       Date:  1999-03       Impact factor: 3.791

2.  A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience.

Authors:  I M Gladstone; R A Ehrenkranz; S C Edberg; R S Baltimore
Journal:  Pediatr Infect Dis J       Date:  1990-11       Impact factor: 2.129

3.  Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.

Authors:  R K Ohls; R D Christensen
Journal:  J Pediatr       Date:  1991-11       Impact factor: 4.406

4.  Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study.

Authors:  D S Halpérin; P Wacker; G Lacourt; M Félix; J F Babel; M Aapro; M Wyss
Journal:  J Pediatr       Date:  1990-05       Impact factor: 4.406

Review 5.  Neutrophil kinetics in the fetus and neonate.

Authors:  R D Christensen
Journal:  Am J Pediatr Hematol Oncol       Date:  1989

6.  Hematologic scoring system in early diagnosis of sepsis in neutropenic newborns.

Authors:  R L Rodwell; K M Taylor; D I Tudehope; P H Gray
Journal:  Pediatr Infect Dis J       Date:  1993-05       Impact factor: 2.129

7.  Development of the immune system in very low birth weight (less than 1500 g) premature infants: concentrations of plasma immunoglobulins and patterns of infections.

Authors:  M Ballow; K L Cates; J C Rowe; C Goetz; C Desbonnet
Journal:  Pediatr Res       Date:  1986-09       Impact factor: 3.756

8.  Neutropenia in high-risk neonates.

Authors:  W D Engle; C R Rosenfeld
Journal:  J Pediatr       Date:  1984-12       Impact factor: 4.406

9.  A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.

Authors:  E R Gillan; R D Christensen; Y Suen; R Ellis; C van de Ven; M S Cairo
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

10.  Human recombinant interferon gamma enhances neonatal polymorphonuclear leukocyte activation and movement, and increases free intracellular calcium.

Authors:  H R Hill; N H Augustine; H S Jaffe
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Neonatal meningitis.

Authors:  P T Heath; N K Nik Yusoff; C J Baker
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-05       Impact factor: 5.747

Review 2.  G-CSF and GM-CSF for treating or preventing neonatal infections.

Authors:  R Carr; N Modi; C Doré
Journal:  Cochrane Database Syst Rev       Date:  2003

3.  Rhodotorula mucilaginosa outbreak in neonatal intensive care unit: microbiological features, clinical presentation, and analysis of related variables.

Authors:  R Perniola; M L Faneschi; E Manso; M Pizzolante; A Rizzo; A Sticchi Damiani; R Longo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-03       Impact factor: 3.267

4.  The effect of granulocyte colony stimulating factor administration on preterm infant with neutropenia and clinical sepsis: a randomized clinical trial.

Authors:  L Borjianyazdi; M Froomandi; M Noori Shadkam; A Hashemi; R Fallah
Journal:  Iran J Ped Hematol Oncol       Date:  2013-04-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.